Generalized Anxiety Disorder 7-Item Scale

Author/s: 
Spitzer, Robert L., Kroenke, Kurt, Williams, Janet B. W.
Date Added: 
October 18, 2018
Journal/Publication: 
Archives of Internal Medicine
Publisher: 
American Medical Association
Publication Date: 
May 22, 2006
Issue: 
10
Volume: 
166
Pages: 
1092-1097
Type: 
Clinical Decision Aids, Practice Management Research Results
Format: 
Article
DOI (1): 
10.1001/archinte.166.10.1092
PMID (1): 
16717171

RPR Commentary

This is the most widely used screening tool for identifying patients with anxiety disorders.  Many practices now include it in their periodic assessment processes.

Abstract

BACKGROUND:

Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity.

METHODS:

A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use.

RESULTS:

A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale.

CONCLUSION:

The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.